未登录

T

Thaís Pincelli

Mayo Clinic

H指数:10

被引数:388

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Updated meta-analysis on the risk of melanoma associated with phosphodiesterase type 5 inhibitors

关于磷酸二酯酶5型抑制剂相关黑色素瘤风险的更新Meta分析

MELANOMA RESEARCH

IF0

2025-10-010

PRE

Reply to Editorial Comment on Benign Noninfectious Scrotal Dermatoses: An Overview

回复关于《良性非感染性阴囊皮肤病：概述》的编辑评论

IF2

2025-10-010

PRE

Benign Non-Infectious Scrotal Dermatoses: An Overview

良性非感染性阴囊皮肤病：概述

IF2

2025-10-010

PRE

Reactive nonsexually related acute genital ulcers: A retrospective analysis of the Mayo Clinic experience

反应性非性传播相关急性生殖器溃疡：梅奥诊所经验的回顾性分析

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2025-01-190

PRE

A Pilot, Single-Blind, Randomized Controlled Study Evaluating the Use of Platelet-Rich Plasma for Hand Skin Rejuvenation

PLASTIC AND RECONSTRUCTIVE SURGERY

IF3.4

2023-10-302

PRE

High-risk adverse drug reactions: consideration of limited dialysis therapy for toxic epidermal necrolysis (TEN)

INTERNATIONAL JOURNAL OF DERMATOLOGY

IF3.2

2023-10-271

PRE

Apremilast for severe recurrent aphthous stomatitis: A prospective pilot study

Apremilast治疗严重复发性口疮性口炎: 一项前瞻性试点研究

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2023-02-013

PRE

Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2022-11-0124

OA

Vasculitis in the setting of COVID-19: From the disease to the vaccine. Report of a case of cutaneous vasculitis after immunization

新型冠状病毒肺炎设置的血管炎: 从疾病到疫苗。预防接种后皮肤血管炎1例报告

DERMATOLOGIC THERAPY

IF3.4

2022-02-204

OA

Urticarial vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg?

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2021-06-0910

OAAI

Livedoid vasculopathy in 75 Brazilian patients in a single-center institution: Clinical, histopathological and therapy evaluation

DERMATOLOGIC THERAPY

IF3.4

2021-02-0718

OA

From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy

DERMATOLOGIC THERAPY

IF3.4

2020-11-309

OAAI

Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues

EXPERIMENTAL DERMATOLOGY

IF3.1

2020-10-306

PREAI

Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab

INTERNATIONAL JOURNAL OF DERMATOLOGY

IF3.2

2020-08-1722

OAAI

Dupilumab as a useful treatment option for prurigo nodularis in an elderly patient with atopic diathesis

INTERNATIONAL JOURNAL OF DERMATOLOGY

IF3.2

2020-06-2010

PREAI

A rare case of multiple variants of porokeratosis in the same patient: The clue of dermoscopy for diagnosis and therapeutical update

DERMATOLOGIC THERAPY

IF3.4

2020-03-022

PREAI

Adipose-derived cellular and cell-derived regenerative therapies in dermatology and aesthetic rejuvenation

AGEING RESEARCH REVIEWS

IF12.4

2019-09-0175

PREAI

Oropharyngeal histoplasmosis: a report of 10 cases

CLINICAL AND EXPERIMENTAL DERMATOLOGY

IF2.8

2019-02-0111

PREAI